引发慢性疾病的风险?

Karger Kompass Dermatologie Pub Date : 2021-01-01 DOI:10.1159/000514081

Evgenia Makrantonaki

{"title":"引发慢性疾病的风险?","authors":"Evgenia Makrantonaki","doi":"10.1159/000514081","DOIUrl":null,"url":null,"abstract":"COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising infection rates, patient groups characterized by an enhanced infection risk will be challenged by the virus. In this context, patients with chronic immune-mediated inflammatory diseases are of particular interest, as these diseases are characterized by an intrinsic immune dysfunction leading to inflammation that may enhance risk for severe infection.","PeriodicalId":501344,"journal":{"name":"Karger Kompass Dermatologie","volume":"51 1","pages":"9-11"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COVID-19: Risiko für Patienten mit chronisch entzündlichen Erkrankungen?\",\"authors\":\"Evgenia Makrantonaki\",\"doi\":\"10.1159/000514081\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising infection rates, patient groups characterized by an enhanced infection risk will be challenged by the virus. In this context, patients with chronic immune-mediated inflammatory diseases are of particular interest, as these diseases are characterized by an intrinsic immune dysfunction leading to inflammation that may enhance risk for severe infection.\",\"PeriodicalId\":501344,\"journal\":{\"name\":\"Karger Kompass Dermatologie\",\"volume\":\"51 1\",\"pages\":\"9-11\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Karger Kompass Dermatologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1159/000514081\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Karger Kompass Dermatologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000514081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

由SARS-CoV-2病毒引起的COVID-19已成为大流行。随着感染率急剧上升，感染风险较高的患者群体将面临病毒的挑战。在这种情况下，慢性免疫介导炎症性疾病的患者特别感兴趣，因为这些疾病的特点是内在免疫功能障碍导致炎症，可能增加严重感染的风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

COVID-19: Risiko für Patienten mit chronisch entzündlichen Erkrankungen?

COVID-19, caused by the SARS-CoV-2 virus, has become pandemic. With sharply rising infection rates, patient groups characterized by an enhanced infection risk will be challenged by the virus. In this context, patients with chronic immune-mediated inflammatory diseases are of particular interest, as these diseases are characterized by an intrinsic immune dysfunction leading to inflammation that may enhance risk for severe infection.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Karger Kompass Dermatologie

自引率

0.00%

发文量